113 related articles for article (PubMed ID: 696099)
1. [Pathogenesis and treatment of torsion dystonia].
Barkhatova VP; Markova ED
Zh Nevropatol Psikhiatr Im S S Korsakova; 1978; 78(8):1121-8. PubMed ID: 696099
[TBL] [Abstract][Full Text] [Related]
2. [Catecholamine excretion in torsion dystonia].
Barkatova VP
Zh Nevropatol Psikhiatr Im S S Korsakova; 1978; 78(4):495-503. PubMed ID: 654723
[TBL] [Abstract][Full Text] [Related]
3. Effect of supplemental ascorbic acid in a case of torsion dystonia.
Mars H
Adv Neurol; 1976; 14():319-27. PubMed ID: 941777
[TBL] [Abstract][Full Text] [Related]
4. Studies of catecholamine metabolism in two hereditary forms of dystonia.
Wotten GF; Eldridge R; Gordon EK; Axelrod J
Trans Am Neurol Assoc; 1973; 98():245-7. PubMed ID: 4784942
[No Abstract] [Full Text] [Related]
5. [Catecholamines metabolism in extrapyramidal disorders in children].
Mosunova TG
Zh Nevropatol Psikhiatr Im S S Korsakova; 1977; 77(10):1466-9. PubMed ID: 930491
[TBL] [Abstract][Full Text] [Related]
6. [Biochemical evaluation of the effectiveness of antiparkinson preparations containing L-DOPA].
Vartanian KZ
Zh Nevropatol Psikhiatr Im S S Korsakova; 1981; 81(12):1777-81. PubMed ID: 6803476
[TBL] [Abstract][Full Text] [Related]
7. [Clinical results of using Nakom in diseases of the nervous system].
Evtushenko SK; Sadekov IA; Samsonenko RA; Mogilevskaia GS; Prokhorova LM; Ostropolets SS; Osadchiĭ VG; Va'skovskaia ME
Zh Nevropatol Psikhiatr Im S S Korsakova; 1989; 89(8):35-7. PubMed ID: 2686319
[TBL] [Abstract][Full Text] [Related]
8. [Features of the functioning of the catecholamine and adrenocortical systems of patients with depression and different degrees of emotional tension].
Anokhina ID; Bol'shakova TD; Bremer GP; Buniatian AF; Ignatenko LL
Zh Nevropatol Psikhiatr Im S S Korsakova; 1986; 86(11):1703-8. PubMed ID: 3101334
[TBL] [Abstract][Full Text] [Related]
9. [Role of catecholamines in the biochemical mechanisms of the pathogenesis of hepatocerebral dystrophy].
Barkhatova VP
Zh Nevropatol Psikhiatr Im S S Korsakova; 1982; 82(7):78-84. PubMed ID: 7124230
[TBL] [Abstract][Full Text] [Related]
10. [Characteristics of the clinical course, pathogenesis and treatment of torsion dystonia in childhood].
Markova ED
Zh Nevropatol Psikhiatr Im S S Korsakova; 1989; 89(8):32-5. PubMed ID: 2588895
[TBL] [Abstract][Full Text] [Related]
11. [Treatment and prognosis of the therapeutic effect of L-DOPA in dystonia musculorum deformans].
Mel'nichuk PV; Minich LN
Zh Nevropatol Psikhiatr Im S S Korsakova; 1979; 79(8):1002-6. PubMed ID: 484133
[TBL] [Abstract][Full Text] [Related]
12. [Dopamine deficiency syndrome in children with specific reaction to the treatment with levodopa preparations].
Shoshina LM; Grinio LP; Mineeva MF
Zh Nevropatol Psikhiatr Im S S Korsakova; 1989; 89(8):27-32. PubMed ID: 2573987
[TBL] [Abstract][Full Text] [Related]
13. [Excretion of catecholamines and tryptophan derivatives in schizophrenia].
Mileikovskii IuA
Zh Nevropatol Psikhiatr Im S S Korsakova; 1976; 76(5):710-4. PubMed ID: 132832
[TBL] [Abstract][Full Text] [Related]
14. [Circadian rhythm of catecholamine excretion, effect of L-DOPA and Nacom in various diseases of the nervous system].
Iadgarov IS
Zh Nevropatol Psikhiatr Im S S Korsakova; 1983; 83(12):1792-6. PubMed ID: 6229955
[TBL] [Abstract][Full Text] [Related]
15. [L-DOPA test for evaluating in vivo catecholamine biosynthesis in normal persons and persons with different diseases].
Vasil'ev VN; Matlina ESh
Vopr Med Khim; 1977; (3):332-8. PubMed ID: 888397
[TBL] [Abstract][Full Text] [Related]
16. [Approaches to the study of dopamine metabolism in various extrapyramidal diseases].
Barkhatova VP; Kandel' EI; Demina EG
Zh Nevropatol Psikhiatr Im S S Korsakova; 1981; 81(7):1021-9. PubMed ID: 6457476
[TBL] [Abstract][Full Text] [Related]
17. [State of the adrenergic and cholinergic systems of schizophrenic patients during the process of psychopharmacotherapy].
Krupenina LB; Vinogradov MV
Zh Nevropatol Psikhiatr Im S S Korsakova; 1980; 80(5):737-45. PubMed ID: 6106335
[TBL] [Abstract][Full Text] [Related]
18. [Effect of a test with 0.1 g of L-DOPA on the dynamics of urinary excretion of catecholamines and DOPA in schizophrenic patients].
Vasil'ev VN
Vopr Med Khim; 1980; 26(6):782-6. PubMed ID: 6779421
[TBL] [Abstract][Full Text] [Related]
19. [Catecholamines, their precursors and metabolites in human fatigue after exertion].
Matlina EA; Vasil'ev VN; Galimov SD
Vopr Med Khim; 1977; (3):369-75. PubMed ID: 888403
[TBL] [Abstract][Full Text] [Related]
20. [Experience with L-DOPA treatment of children with dystonia musculorum deformans and dystonic hyperkineses in infantile cerebral palsy].
Bondarenko ES; Malyshev IuI
Zh Nevropatol Psikhiatr Im S S Korsakova; 1985; 85(10):1471-5. PubMed ID: 4072505
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
